# Malaria vaccine shows 87% efficacy in clinical trial

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-malaria-vaccine-efficacy-clinical-trial.html) · 2026-11-20 · Medicine
Page: https://themorning.science/story/malaria-vaccine-shows-87-efficacy-in-clinical-trial-6e4b8f013f2ed335
Kind: research · Impact: medium

## In brief

- A genetically attenuated whole-parasite malaria vaccine, PfSPZ-LARC2, showed 87% efficacy in preventing infection in a recent phase 1 trial.
- The figure is reported by Medical Xpress in a story dated 2026-11-20.
- The source does not give trial size, population, or follow-up details.

## Why it matters

A reported 87% efficacy against infection in a phase 1 trial is an early signal for a whole-parasite malaria vaccine approach, but phase 1 results alone do not establish protection in wider populations.

## Coverage

- [Malaria vaccine shows 87% efficacy in clinical trial](https://medicalxpress.com/news/2026-11-malaria-vaccine-efficacy-clinical-trial.html) — Medical Xpress - latest medical and health news stories, 2026-11-20

Tags: malaria, vaccine, clinical-trial, infectious-disease, whole-parasite-vaccine

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
